Loading company…
Tianjin-based in-vitro diagnostics maker, founded in 2010, whose microfluidic analyzers are used in more than 20 countries.
Tianjin MNCHIP Technologies Co., Ltd, trading as MNChip and founded in 2010 in Tianjin, China, develops rapid in-vitro diagnostic tools using microfluidic technology. Its Celercare and Pointcare analyzers are used by healthcare and veterinary institutions in over 20 countries, and it had supplied more than 20,000 devices as of 2022. In November 2023 the company closed a venture funding round from China Merchants Capital and Fortune Capital, and it is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in